Arcadia Biosciences (RKDA) Misses Q2 EPS by 3c

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($0.10), $0.03 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $721 thousand versus the consensus estimate of $1.9 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Green Dot and CommerceOne shareholders approve acquisition deal
• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI